• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK SE & CO. KG EVIA DR-T; PACEMAKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK SE & CO. KG EVIA DR-T; PACEMAKER Back to Search Results
Model Number 359529
Device Problem Premature Elective Replacement Indicator (1483)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/24/2016
Event Type  malfunction  
Manufacturer Narrative
As of today, the medical device is not available for analysis, therefore the device itself could not be investigated.The analysis is thus based on the inspection of the quality documents associated with the manufacture of this particular device as well as the data returned for evaluation.The manufacturing process for this device was re-investigated.All production steps had been performed accordingly.There was no sign of any inconsistency during the manufacturing process.Particularly the final acceptance test proved the device functions to be as specified.The returned data were inspected.Upon inspection of the data the clinical observation was confirmed.The remaining battery capacity is 15% and the eri estimation is less than 1 month.Further analysis of the data revealed that the clinical observation resulted from a temporarily elevated current consumption.The root cause of this observation could not be determined based on the information available for analysis.However, the data did not reveal any indication of a pacemaker malfunction.In summary, the device was not returned for analysis.The review of the quality documents confirmed a regular device manufacturing.The analysis of the returned device data confirmed the battery status of 15% remaining capacity, which resulted from a temporarily elevated current consumption.Based on the information available for analysis the root cause of this observation could not be determined, however, there was no indication of a pacemaker malfunction.Should the device itself become available for analysis, this investigation will be updated.
 
Event Description
Ous mdr - it was reported that approx.79 months after the implantation a battery depletion with a remaining battery capacity 1 month and less than 15% was noted.The pacemaker was not returned to biotronik and no explant date was provided.No adverse patient side effects have been reported.
 
Manufacturer Narrative
The device was received and analyzed.Prior to the analysis of the device, the manufacturing process for this pacemaker was re-investigated.All production steps had been performed accordingly.There was no sign of any inconsistency during the manufacturing process.Particularly the final acceptance test proved the device functions to be as specified.At a next step the returned data were inspected.Upon inspection of the data the clinical observation was confirmed.Further analysis of the data revealed that the clinical observation resulted from a temporarily elevated current consumption.The root cause of this observation could not be determined based on the information available for analysis.However, the data did not reveal any indication of a pacemaker malfunction.At a next step the pacemaker was subjected to an electrical analysis.The device interrogation revealed the battery status eri.The ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.The pacemaker functioned as expected showing no anomalies.In summary, the device proved to be fully functional during analysis.The review of the quality documents confirmed a regular device manufacturing.The analysis revealed a temporarily slightly elevated current consumption leading to the clinical observation.Based on the information available for analysis the root cause of this observation could not be determined, however, there was no indication of a pacemaker malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIA DR-T
Type of Device
PACEMAKER
Manufacturer (Section D)
BIOTRONIK SE & CO. KG
woermannkehre 1
berlin D-123 59
GM  D-12359
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key6215409
MDR Text Key63626174
Report Number1028232-2016-05040
Device Sequence Number1
Product Code NVZ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P950037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number359529
Device Catalogue NumberSEE MODEL NO.
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/07/2016
Initial Date FDA Received12/30/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/24/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/23/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-